Comorbidities in childhood associated with extrauterine growth restriction in preterm infants: a scoping review

M D Martínez-Jiménez1, F J Gómez-García2, M Gil-Campos3

  • 1Neonatology Unit. Reina Sofia University Hospital; Pediatric Research Unit, Maimónides Biomedical Research Institute of Córdoba (IMIBIC), University of Córdoba, Córdoba, Spain.

Insights

Extrauterine growth restriction (EUGR) in preterm infants is linked to poor childhood growth, neurodevelopment, and cardiometabolic issues. A standardized definition is needed to better understand long-term outcomes and risks.

Area of Science:

  • Neonatalogy
  • Pediatric Health
  • Developmental Pediatrics

Background:

  • Extrauterine growth restriction (EUGR) is a common complication in preterm infants.
  • EUGR can negatively impact short- and long-term health outcomes, including growth, neurological development, and cardiometabolic risk.
  • Existing knowledge on the long-term prognosis of EUGR is limited.

Purpose of the Study:

  • To systematically review the existing evidence on comorbidities associated with EUGR in childhood.
  • To synthesize current understanding of EUGR's impact on growth, neurodevelopment, and cardiometabolic health.

Main Methods:

  • A systematic scoping review was conducted using the Joanna Briggs Institute Reviewers' Manual Methodology and PRISMA-Search Extension.
  • Literature search was performed on MEDLINE and EMBASE databases for studies published up to September 2017.
  • Twenty-four publications were included, with 19 being cohort studies.

Main Results:

  • EUGR in childhood is primarily associated with reduced measures of weight, length, and head circumference.
  • Poor neurodevelopmental outcomes are frequently observed in children with EUGR.
  • Alterations in cardiometabolic risk markers are also linked to EUGR.

Conclusions:

  • EUGR is significantly associated with impaired growth, neurodevelopment, and cardiometabolic alterations in childhood.
  • The current evidence is derived from observational studies with considerable variability in definitions and studied populations.
  • Establishing a gold standard definition for EUGR is crucial for accurate phenotyping and predicting long-term risks.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.0K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.9K
Factors Affecting Illness01:18

Factors Affecting Illness

When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
4.9K
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
664
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K